Latest Articles
Morning Live star suffered 'incredible pain' for decades before welcoming first child - Manchester Evening News
Morning Live star suffered 'incredible pain' for decades before welcoming first child Manchester Evening News
Published: Feb. 11, 2026, 12:51 p.m.
Morning Live’s Michelle Ackerley opens up on 20-year health battle before falling pregnant - Female First
Morning Live’s Michelle Ackerley opens up on 20-year health battle before falling pregnant Female First
Published: Feb. 11, 2026, 12:31 p.m.
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb - openPR.com
Endometrial Cancer Treatment Market Is Going to Boom |• Merck & Co. • Bristol-Myers Squibb openPR.com
Published: Feb. 11, 2026, 12:24 p.m.
Doctor urges one in four women to get checked for 'silent' medical condition - Lancs Live
Doctor urges one in four women to get checked for 'silent' medical condition Lancs Live
Published: Feb. 11, 2026, 10:41 a.m.
Morning Live star reveals agonising health battle before having miracle baby - The Irish Sun
Morning Live star reveals agonising health battle before having miracle baby The Irish Sun
Published: Feb. 11, 2026, 10:26 a.m.
India RAISE Awards 2026: Elsevier Honors Responsible AI in Indian Healthcare - Medical Dialogues
India RAISE Awards 2026: Elsevier Honors Responsible AI in Indian Healthcare Medical Dialogues
Published: Feb. 11, 2026, 10:25 a.m.
Dual role of the endometrial microbiome-immune axis: From endometrial | IJWH - Dove Medical Press
Dual role of the endometrial microbiome-immune axis: From endometrial | IJWH Dove Medical Press
Published: Feb. 11, 2026, 9:02 a.m.
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk - Medscape
GLP-1s Plus Progestins Tied to Lower Endometrial Cancer Risk Medscape
Published: Feb. 11, 2026, 8:49 a.m.
Research project of the year: What the judges want to see - FemTech World
Research project of the year: What the judges want to see FemTech World
Published: Feb. 11, 2026, 8:36 a.m.
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment - NewsGram
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment NewsGram
Published: Feb. 11, 2026, 3:33 a.m.
Link copied to clipboard!